Skip to main content
OSR Holdings, Inc. logo

OSR Holdings, Inc. — Investor Relations & Filings

Ticker · OSRH ISIN · US68840D1028 US Professional, scientific and technical activities
Filings indexed 204 across all filing types
Latest filing 2024-02-29 Regulatory Filings
Country US United States of America
Listing US OSRH

About OSR Holdings, Inc.

https://osr-holdings.com/

OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm to the SEC regarding the confidential submission of a draft Registration Statement on Form S-4. It is a correspondence about a filing process, not the filing itself or a report containing financial data. The document is short (1087 characters) and serves as a notification or regulatory correspondence. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and correspondence that do not fit other specific categories.
2024-02-29 English
Merger & Acquisition 2024
Merger & Acquisition Classification · 100% confidence The document is a confidential draft registration statement on Form S-4 filed with the SEC, which includes a preliminary proxy statement and prospectus related to a business combination (merger) involving Bellevue Life Sciences Acquisition Corp. The text discusses the business combination proposal, issuance of shares, governance proposals, and related shareholder meeting details. Form S-4 is specifically used for registration of securities in connection with mergers and acquisitions. The document is not a financial report, earnings release, or a simple announcement but a detailed filing related to a merger transaction. Therefore, the appropriate classification is Merger & Acquisition (MA). The document length and content confirm it is the filing itself, not just an announcement or proxy solicitation alone.
2024-02-29 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is a notice from Nasdaq that the company no longer meets the minimum public holders requirement and has received a delisting warning. The document specifically mentions 'Notice of Delisting' and details about compliance deadlines and potential extensions. The document length is 3820 characters, which is relatively short and focused on the delisting notice rather than a full financial report or other types of filings. Therefore, this document is best classified as a Delisting Announcement (DLST).
2024-02-21 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used to announce major events or changes that shareholders should know about. The content includes the issuance of a promissory note to a board member, an amendment to the company's certificate of incorporation extending the deadline for a business combination, and a deposit into a trust account related to that extension. There are no financial statements or detailed financial performance data included, nor is this a full annual or quarterly report. The document primarily announces corporate actions and agreements, which fits the category of a Regulatory Filing (RNS) as it does not fit into more specific categories like capital updates or management changes. The length and detail also confirm it is not a brief announcement but a formal regulatory filing.
2024-02-13 English
SCHEDULE 13G
Major Shareholding Notification
2024-02-08 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.